Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | CASP7 | P55210 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 2/20 | 0.35 |
| ▸ | CDC14B | O60729 | 1/20 | 0.35 |
| ▸ | CDC14A | Q9UNH5 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9099410 | 0.85 | ALOX5 (0.36) | PGRALOX5GGPS1PTGS2DYRK1A | |
| SCHEMBL17614151 | 0.84 | ALOX5 (0.42) | ALOX5GGPS1MAOAMAPTKDM4E | |
| SCHEMBL29512043 | 0.84 | ALOX5 (0.42) | ALOX5GGPS1MAOAMAPTKDM4E | |
| SCHEMBL18156750 | 0.79 | GGPS1 (0.35) | PGRALOX5GGPS1 | |
| SCHEMBL21019245 | 0.76 | MEN1 (0.36) | GGPS1DYRK1AMAPTKDM4ECYP3A4 | |
| SCHEMBL16440654 | 0.75 | PLA2G2A (0.41) | ALOX5GGPS1MAPTKDM4EHPGD | |
| SCHEMBL11990930 | 0.73 | GGPS1 (0.44) | ALOX5GGPS1PTGS2MAOAMAPT | |
| SCHEMBL9927219 | 0.73 | NPSR1 (0.44) | MAPTKDM4ECYP3A4ALDH1A1MEN1 | |
| SCHEMBL21019637 | 0.73 | CDC14B (0.39) | MAOAMAPTKDM4ECYP3A4HPGD | |
| SCHEMBL16440830 | 0.73 | ALOX5 (0.54) | ALOX5GGPS1MAOAKDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1801093-B1 | Process for the Preparation of enantiomer-enriched 2-Alkoxy-3-Phenyl-Propionic Acid | SALTIGO GMBH (DE) | 2009-03-18 | — | — | EP | claimed |
| US-7429676-B2 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | SALTIGO GMBH (DE) | 2008-09-30 | — | — | US | claimed |
| US-20070149804-A1 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | SALTIGO GMBH (DE) | 2007-06-28 | — | — | US | claimed |
| US-7429676-B2 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | SALTIGO GMBH (DE) | 2008-09-30 | — | — | US | disclosed |
| US-20070149804-A1 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | SALTIGO GMBH (DE) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149804-A1 | Process for preparing enantiomerically enriched 2-alkoxy-3-phenylpropionic acids | HPD, PAH, APEH | PGR 1911/4885ALOX5 638/4885GGPS1 871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.